However, recent expert consensus guidelines recommend genetic confirmation as essential, defining Alport syndrome more broadly to include all individuals harboring pathogenic variants in COL4A3, COL4A4, or COL4A5, regardless of their clinical presentation (6–8). The gene discussed is COL4A5; the disease is Alport syndrome.